Continuity Biosciences, LLC, is dedicated to developing and commercializing cutting-edge technologies for cell reprogramming, immune modulation, and ultra-long acting drug delivery. The company seeks to leverage the immense potential at the intersection of biopharmaceuticals and medical technologies, especially in creating combination products that can help realize the full potential of remarkable therapies. While their foundation is built on technologies licensed from Prof. Grattoni’s pioneering research at the Houston Methodist Hospital, they plan to continuously expand their technology portfolio to provide their partners with diverse options for their product presentation strategies.
